USFDA inspection at Zydus' injectables manufacturing facility at Zydus Biotech Park, concludes with Nil observations

Zydus Lifesciences Ltd., today announced that the group's injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad, underwent USFDA inspection from 5th June to 13 June, 2023. The cGMP inspection concluded with nil observations.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 517.70 as compared to the previous close of Rs. 509.95. The total number of shares traded during the day was 31775 in over 1738 trades.

The stock hit an intraday high of Rs. 519.10 and intraday low of 508.80. The net turnover during the day was Rs. 16368493.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 USFDA Inspection ZydusBiotechPark Injectables ManufacturingFacility ZeroObservations